Coloplast A/S (FRA:CBHD)
Germany
· Delayed Price · Currency is EUR 76.82
+1.05 (1.38%)
At close: Dec 5, 2025
Revenue
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2013 - 2020 |
| Ostomy Care Revenue | 9.90B |
Log In |
Log In |
Log In | Upgrade
|
| Continence Care Revenue | 8.98B |
Log In |
Log In |
Log In | Upgrade
|
| Chronic Care Revenue | 18.88B |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Revenue | 2.28B |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Revenue | 2.78B |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Dressings Revenue | 2.68B |
Log In |
Log In |
Log In | Upgrade
|
| Biologics Revenue | 1.25B |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Care Revenue | 3.93B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2013 - 2020 |
| European Markets Revenue | 15.51B |
Log In |
Log In |
Log In | Upgrade
|
| Other Developed Markets Revenue | 7.83B |
Log In |
Log In |
Log In | Upgrade
|
| Emerging Markets Revenue | 4.54B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2013 - 2020 |
| Chronic Care Segment EBIT | 11.06B |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Segment EBIT | 837.00M |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Segment EBIT | 984.00M |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Dressings Segment EBIT | 1.11B |
Log In |
Log In |
Log In | Upgrade
|
| Biologics Segment EBIT | 159.00M |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Care Segment EBIT | 1.26B |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is October - September.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | 2013 - 2020 |
| Ostomy Care Organic Growth | 6.00% |
Log In |
Log In |
Log In | Upgrade
|
| Continence Care Organic Growth | 8.00% |
Log In |
Log In |
Log In | Upgrade
|
| Voice and Respiratory Care Organic Growth | 9.00% |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Wound Care Organic Growth | 8.00% |
Log In |
Log In |
Log In | Upgrade
|
| Interventional Urology Organic Growth | 2.00% |
Log In |
Log In |
Log In | Upgrade
|
| Total Organic Growth | 7.00% |
Log In |
Log In |
Log In | Upgrade
|